JANX
NASDAQStockJanux Therapeutics, Inc.
$13.48-0.47 (-3.33%)
52-Week Range
$12.18
$34.74
Key Stats
Market Cap
820.0M
P/E Ratio
—
Dividend Yield
—
Beta
2.88
Volume
795.1K
Avg Volume
811.7K
Performance
1M
+6.21%
3M
-7.77%
6M
-40.81%
YTD
+2.16%
1Y
-54.55%
3Y
+5.32%
5Y
-44.55%
Price Chart
ETF Exposure
JANX is held by 92 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| WSML | iShares MSCI World Small-Cap ETF | 0.01% |
| WSML.L | iShares MSCI World Small Cap UCITS ETF | 0.01% |
| DXUV | Dimensional - US Vector Equity ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| WDSC.L | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.00% |
| WOSC.L | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.00% |
| ZPRS.DE | State Street SPDR MSCI World Small Cap UCITS ETF (Acc) | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| ZPRV.DE | State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.00% |
| CBUG.DE | iShares $ Treasury Bond 3-7yr UCITS ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.00% |
| USFM.L | UBS MSCI USA Select Factor Mix UCITS ETF USD dis | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| IMID.L | State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc) | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| SPYI.DE | State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc) | 0.00% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
PreviousPage 2 of 2
About JANX ETF Exposure
Janux Therapeutics, Inc. (JANX) is held by 92 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 820.0M, JANX is a widely held institutional stock. The stock currently trades at $13.48. Investors can gain exposure to JANX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold JANX, sorted by portfolio weight.